Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
October 28 2008 - 4:05PM
PR Newswire (US)
CAMBRIDGE, Mass., Oct. 28 /PRNewswire-FirstCall/ -- Idenix
Pharmaceuticals, Inc. (NASDAQ:IDIX) announced today that management
will present a corporate overview at the upcoming Oppenheimer 19th
Annual Healthcare Conference on Tuesday, November 4th at 2:00p.m.
ET in New York at the Waldorf Astoria and at the Barclays Capital
Small & Mid-Cap Healthcare Forum on Thursday, November 6th at
8:30a.m. at Barclays Capital, 745 Seventh Avenue in New York. The
live and archived webcasts of the presentations can be accessed
under "Calendar of Events" in the Idenix Investor Center at
http://www.idenix.com/. Please log in approximately 5-10 minutes
before the events to ensure a timely connection. The archived
replays will be available on the Idenix website for two weeks
following the conferences. About Idenix Idenix Pharmaceuticals,
Inc., headquartered in Cambridge, Massachusetts, is a
biopharmaceutical company engaged in the discovery and development
of drugs for the treatment of human viral and other infectious
diseases. Idenix's current focus is on the treatment of infections
caused by the hepatitis C virus and HIV. For further information
about Idenix, please refer to http://www.idenix.com/. Idenix
Pharmaceuticals' Contacts: Media: Teri Dahlman (617) 995-9905
Investors: Amy Sullivan (617) 995-9838 DATASOURCE: Idenix
Pharmaceuticals, Inc. CONTACT: Media: Teri Dahlman,
+1-617-995-9905, or Investors: Amy Sullivan, +1-617-995-9838, both
of Idenix Pharmaceuticals, Inc. Web site: http://www.idenix.com/
Copyright
(MM) (NASDAQ:IDIX)
Historical Stock Chart
From Jun 2024 to Jul 2024
(MM) (NASDAQ:IDIX)
Historical Stock Chart
From Jul 2023 to Jul 2024